A metalloproteinase inhibitor as an inhibitor of neovascularization - PubMed (original) (raw)

Review

A metalloproteinase inhibitor as an inhibitor of neovascularization

M A Moses et al. J Cell Biochem. 1991 Nov.

Abstract

Metalloproteinases and their endogenous inhibitors are key components of an enzyme system which is important in a number of fundamental biochemical and cellular processes. Our recent work has focused on the role of a particular metalloproteinase, collagenase, and the role of an endogenous inhibitor of this enzyme in the control of neovascularization. The proteolytic degradation of extracellular matrix components by capillary endothelial cells (EC) has been shown to be one of the key prerequisites of the angiogenic process. As part of a study of the effect(s) of the inhibition of collagenase on neovascularization, we have recently reported the purification, characterization and partial NH2-terminal sequence of a cartilage-derived inhibitor (CDI) of angiogenesis in vivo and in vitro. Evidence is presented which suggests that one means of controlling deregulated vascular growth characteristic of a number of "angiogenic diseases" may be at the level of the control of metalloproteinase activity.

PubMed Disclaimer

Similar articles

• The regulation of neovascularization of matrix metalloproteinases and their inhibitors.
  Moses MA. Moses MA. Stem Cells. 1997;15(3):180-9. doi: 10.1002/stem.150180. Stem Cells. 1997. PMID: 9170209 Review.
• The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.
  Ray JM, Stetler-Stevenson WG. Ray JM, et al. Eur Respir J. 1994 Nov;7(11):2062-72. Eur Respir J. 1994. PMID: 7533104 Review.
• The regulation of connective tissue metalloproteinases by natural inhibitors.
  Murphy G. Murphy G. Agents Actions Suppl. 1991;35:69-76. Agents Actions Suppl. 1991. PMID: 1781423 Review.
• Matrix metalloproteinases and their inhibitors in aqueous humor.
  Huang SH, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA. Huang SH, et al. Exp Eye Res. 1996 May;62(5):481-90. doi: 10.1006/exer.1996.0058. Exp Eye Res. 1996. PMID: 8759516

Cited by

• Tumor invasion, proteolysis, and angiogenesis.
  Thorgeirsson UP, Lindsay CK, Cottam DW, Gomez DE. Thorgeirsson UP, et al. J Neurooncol. 1994;18(2):89-103. doi: 10.1007/BF01050415. J Neurooncol. 1994. PMID: 7525888 Review.
• The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.
  Cox G, Steward WP, O'Byrne KJ. Cox G, et al. Thorax. 1999 Feb;54(2):169-79. doi: 10.1136/thx.54.2.169. Thorax. 1999. PMID: 10325924 Free PMC article. Review. No abstract available.
• Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes.
  Moses MA, Sudhalter J, Langer R. Moses MA, et al. J Cell Biol. 1992 Oct;119(2):475-82. doi: 10.1083/jcb.119.2.475. J Cell Biol. 1992. PMID: 1383232 Free PMC article.
• TIMP-2 is required for efficient activation of proMMP-2 in vivo.
  Wang Z, Juttermann R, Soloway PD. Wang Z, et al. J Biol Chem. 2000 Aug 25;275(34):26411-5. doi: 10.1074/jbc.M001270200. J Biol Chem. 2000. PMID: 10827175 Free PMC article.
• Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.
  MacDougall JR, Matrisian LM. MacDougall JR, et al. Cancer Metastasis Rev. 1995 Dec;14(4):351-62. doi: 10.1007/BF00690603. Cancer Metastasis Rev. 1995. PMID: 8821095 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program